alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 08-6035

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

v.

BERNARD GIBSON, SR.,

Defendant - Appellant.

Appeal from the United States District Court for the District of

Maryland, at Greenbelt. Peter J. Messitte, District Judge. (8:94-

cr-00454-PJM-2; 8:05-cv-01437-PJM)

Submitted: February 28, 2008 Decided: March 10, 2008

Before WILKINSON, NIEMEYER, and MICHAEL, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Bernard Gibson, Sr., Appellant Pro Se. Sandra Wilkinson, Assistant

United States Attorney, Baltimore, Maryland, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

Certiorari dismissed, November 3, 2008
- 2 -

PER CURIAM:

Bernard Gibson, Sr., seeks to appeal the district court’s

order denying relief on his motion to amend his motion filed under

28 U.S.C. § 2255 (2000), and the court’s order denying his motion

to reconsider. The district court found that there was no pending

§ 2255 motion to amend and that, in any event, Gibson’s motions

were tantamount to a successive § 2255 motion, for which Gibson had

not obtained authorization to file. The orders are not appealable

unless a circuit justice or judge issues a certificate of

appealability. 28 U.S.C. § 2253(c)(1) (2000). A certificate of

appealability will not issue absent “a substantial showing of the

denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2000).

A prisoner satisfies this standard by demonstrating that reasonable

jurists would find that any assessment of the constitutional claims

by the district court is debatable or wrong and that any

dispositive procedural ruling by the district court is likewise

debatable. Miller-El v. Cockrell, 537 U.S. 322, 336-38 (2003);

Slack v. McDaniel, 529 U.S. 473, 484 (2000); Rose v. Lee, 252 F.3d

676, 683-84 (4th Cir. 2001). We have independently reviewed the

record and conclude that Gibson has not made the requisite showing.

Accordingly, we deny a certificate of appealability and dismiss the

appeal. We dispense with oral argument because the facts and legal
- 3 -

contentions are adequately presented in the materials before the

court and argument would not aid the decisional process.

DISMISSED
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 98-7636

JOHN GEORGE SIMKUS, JR., Petitioner - Appellant, versus FRANK C. SIZER, JR., Warden; J. JOSEPH CURRAN, JR., Respondents - Appellees. Appeal from the United States District Court for the District of Maryland, at Baltimore. William M. Nickerson, District Judge. (CA-98-1417-WMN) Submitted: May 28, 1999 Decided: June 15, 1999 Before MOTZ, TRAXLER, and KING, Circuit Judges. Dismissed by unpublished per curiam opinion. John George Simkus, Jr., Appellant Pro Se. John Joseph Curran, Jr., Attorney General, Regina Hollins Lewis, Assistant Attorney General, Baltimore, Maryland, for Appellees. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: John George Simkus, Jr., seeks to appeal the district court’s order denying relief on his petition filed under 28 U.S.C.A. § 2254(West 1994 & Supp. 1999). We have reviewed the record and the district court’s opinion and find no reversible error. Accordingly, we deny Simkus’ motions for a certificate of appealability and appointment of counsel, and we dismiss the appeal on the reasoning of the district court. See Simkus v. Sizer , No. CA-98-1417-WMN (D. Md. Oct. 9, 1998). We dispense with oral argument because thefacts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
Consent of Kesselman & Kesselman



 Exhibit 10.1 
 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 
 We hereby consent to the incorporation by reference
in the Registration Statements on Form F-3 (No. 333-131387, No 333-130534 and No. 333-111132) and on Form S-8 (No. 333-131274) of Teva Pharmaceutical Industries Limited of our report dated February 28, 2007 relating to the consolidated
financial statements, management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting, which are included in Teva Pharmaceutical Industries Limited
Annual Report on Form 20-F for the year ended December 31, 2006. We also consent to the incorporation by reference of our report dated February 28, 2007 relating to the Financial Statement Schedule, which appears in this Form 20-F.

  

			
	Tel-Aviv, Israel	 	/s/ Kesselman & Kesselman
	    February 28, 2007	 	Certified Public Accountants (Isr.)
		 	 A member of PricewaterhouseCoopers
 International Limited
<PAGE>

EXHIBIT 32.1


      CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


        In connection with the quarterly report on Form 10-Q of MicroTel
International, Inc. (the "Company") for the quarterly period ended June 30, 2003
(the "Report"), the undersigned hereby certify in their capacities as Chief
Executive Officer and Chief Financial Officer of the Company, respectively,
pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

        1. the Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended; and

        2. the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated: August 14, 2003                 By: /s/ CARMINE T. OLIVA
                                            ------------------------------------
                                            Carmine T. Oliva
                                            Chief Executive Officer (principal
                                            executive officer)


Dated: August 14, 2003                 By: /s/ RANDOLPH D. FOOTE
                                            ------------------------------------
                                            Randolph D. Foote
                                            Chief Financial Officer (principal
                                            financial officer)

         A signed original of this written statement required by Section 906, or
other document authenticating, acknowledging, or otherwise adopting the
signatures that appear in typed form within the electronic version of this
written statement required by Section 906, has been provided to the Company and
will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.
Filed: April 29, 2003 UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 03-1217 (CA-02-112-5-BO) Victor Byrd, Plaintiff - Appellant, versus North Carolina State University, etc., Defendant - Appellee.

O R D E R The court amends its opinion filed April 22, 2003, as follows: On the cover s heet, section 7, line 1 -- counsel’s name is corrected to read “Celia Grasty Lata.” For the Court - By Direction

/s/ Patricia S. Connor ClerkUNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 03-1217 VICTOR BYRD, Plaintiff - Appellant, versus NORTH CAROLINA STATE UNIVERSITY, University Temporary Services, Defendant - Appellee. Appeal from the United States District Court for the Eastern District of North Carolina, at Raleigh. Terrence W. Boyle, Chief District Judge. (CA-02-112-5-BO) Submitted: April 17, 2003 Decided: April 22, 2003 Before WIDENER, WILLIAMS, and MOTZ, Circuit Judges. Affirmed by unpublished per curiam opinion. Victor Byrd, Appellant Pro Se. Celia Grasty Lata, OFFICE OF THE ATTORNEY GENERAL OF NORTH CAROLINA, Raleigh, North Carolina, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).3 PER CURIAM: Victor Byrd appeals the district court’s order dismissing his civil action alleging employment discrimination under the Americans with Di sabilities Act. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. SeeByrd v. North Carolina State Univ. , No. CA02-112-5-BO (E.D.N.C. Feb. 5, 2003). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta name="pdf:PDFVersion" content="1.2">
<meta name="xmp:CreatorTool" content="Acrobat Capture Server 2.0">
<meta name="pdf:hasXFA" content="false">
<meta name="access_permission:modify_annotations" content="true">
<meta name="dc:creator" content="capture">
<meta name="dcterms:created" content="1998-06-02T19:30:07Z">
<meta name="dcterms:modified" content="1998-06-02T19:30:10Z">
<meta name="dc:format" content="application/pdf; version=1.2">
<meta name="pdf:docinfo:creator_tool" content="Acrobat Capture Server 2.0">
<meta name="access_permission:fill_in_form" content="true">
<meta name="pdf:docinfo:modified" content="1998-06-02T19:30:10Z">
<meta name="pdf:hasCollection" content="false">
<meta name="pdf:encrypted" content="false">
<meta name="Content-Length" content="61994">
<meta name="pdf:hasMarkedContent" content="false">
<meta name="Content-Type" content="application/pdf">
<meta name="access_permission:can_print_faithful" content="true">
<meta name="pdf:docinfo:creator" content="capture">
<meta name="pdf:producer" content="Acrobat PDFWriter 3.02 for Windows NT">
<meta name="access_permission:extract_for_accessibility" content="true">
<meta name="access_permission:assemble_document" content="true">
<meta name="xmpTPg:NPages" content="2">
<meta name="pdf:hasXMP" content="false">
<meta name="access_permission:extract_content" content="true">
<meta name="access_permission:can_print" content="true">
<meta name="X-TIKA:Parsed-By" content="org.apache.tika.parser.DefaultParser">
<meta name="X-TIKA:Parsed-By" content="org.apache.tika.parser.pdf.PDFParser">
<meta name="access_permission:can_modify" content="true">
<meta name="pdf:docinfo:producer" content="Acrobat PDFWriter 3.02 for Windows NT">
<meta name="pdf:docinfo:created" content="1998-06-02T19:30:07Z">
<title></title>
</head>
<body><div class="page"><p></p>
<p>OFFICE OF THE ATTORNEY GENERAL OF TEXAS 
AUSTIN </p>
<p></p>
</div>
<div class="page"><p></p>
<div class="ocr">410
lire Jo Gs Gowly + page 2

ranged in oi poabetioal onder

with the roll withidraen to ala

the mst assossmont « The Liste ant
gstatcnents shal] be rites in the 60 goun cmty
Oloriu's office, aml romain there for

the inspection’ of the publict,

Unmdicr the in, Frorisdons of tho above
articies, thase ort 1 Lists ef inven renditions
should be the Tax Agsesso:Collector in
ai phabetiaad » ond Sliled in the County Clerkts
office, ond ths County Clork is thereafter the custo-
dian of BOI «

Vory traly yours
ATTORNEY QEHERAL OF TEXAS

by
Goo, Ve Barcus
Assistant

APPRO ) 1939
GUD ;

FIRST ASSTSTAN
ATTORNEY Gi¢lRAL

APPROVED

OPINION
COMMiTTEg

Sy.
</div>

</div>
</body></html>
COURT OF APPEALS

SECOND DISTRICT OF TEXAS 

FORT WORTH 

NO. 02-16-00219-CV 

Larry Joe Morgan 

v. 

Richard Scott Walker 

§ 

§ 

§ 

§ 

From the 236th District Court 

of Tarrant County (236-282599-15) 

August 18, 2016 

Per Curiam 

JUDGMENT 

This court has considered the record on appeal in this case and holds that 

the appeal should be dismissed. It is ordered that the appeal is dismissed for 

want of jurisdiction. 

SECOND DISTRICT COURT OF APPEALS 

PER CURIAM
[Federal Register Volume 74, Number 17 (Wednesday, January 28, 2009)]
[Notices]
[Page 4964]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-1856]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Bacillus Anthracis Program Project.
    Date: February 19, 2009.
    Time: 12 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700-B Rockledge Drive, 
Room 3122, Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Brenda Lange-Gustafson, PhD, Scientific Review 
Officer, NIAID/NIH/DHHS, Scientific Review Program, Room 3122, 6700-
B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-451-3684, 
<a href="/cdn-cgi/l/email-protection#bcdedbc9cfc8dddacfd3d2fcd2d5ddd5d892d2d5d492dbd3ca"><span class="__cf_email__" data-cfemail="7a181d0f090e1b1c0915143a14131b131e54141312541d150c">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 22, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-1856 Filed 1-27-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.1



Certification Pursuant to § 906 of the Sarbanes-Oxley Act of 2002



Pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the
Sarbanes-Oxley Act of 2002, in connection with the filing of the Form 10-Q of STERIS Corporation (the Company) for the quarter ended December 31, 2005, as filed with the Securities and Exchange Commission on the date hereof (the
Report), each of the undersigned officers of the Company certifies, that, to such officers knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the
periods expressed in the Report.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



/s/    LES C. VINNEYName:

Les C. VinneyTitle:

President and Chief Executive Officer (Principal Executive Officer)




/s/    LAURIE BRLASName:

Laurie BrlasTitle:

Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)




Dated: February 7, 2006
Document Control Office (7407 M) Office of Pollution Prevention and Toxics (OPPT) Environmental Protection Agency EPA East Building , Room E6428 (202-564-8930) 1201 Constitution Avenue , NW Washington , DC 20460 Attention: TSCA Section 4 Docket ID Number EPA-HQ-OPPT-2009-0112 To Whom It May Concern : 

# !i sOCMA Society of Chemica Manufacturers &Affiliates

July 6, 2015

RE: Testing of Certain High Production Volume Chemicals; Third Group of Chemicals. Federal Register 76 (204), 65385-65410, October 21, 2011. 1-Propanesulfonic acid, 2-hydroxy-3-(2-propen-1-yloxy)-, sodium salt (1: 1) (CAS No. 52556-42-0) Submission of Final Reports The COPS-1 Consortium , a cost-sharing consortium formed and managed by the Society of Chemical Manufacturers and Affiliates (SOCMA) , submits these two final reports to satisfy the testing requirements ofthe subject test rule for 1-propanesulfonic acid , 2-hydroxy-3-(2-propen-1-yloxy)-, sodium salt (1 :1) (CAS No. 52556-42-0) , also known as COPS-1 . On June 16, 2014 the COPS-1 Consortium submitted a new test plan to respond to a request from EPA's Dr. Paul Lewis on April 28, 2014 to repeat the gene mutation and chromosome aberration studies. The results of those tests had been submitted earlier (August 28, 2013) but were found by EPA reviewers to be inadequate to satisfy the HPV 3 test rule. The Consortium agreed to repeat those studies accordingly. The final reports for those repeat studies are submitted here: • Gene Mutations: Bacterial Reverse Mutation Test (in vitro) : 40 CFR 799.9510 (OECD471 ). • Mammalian (chromosomal damage): In vitro mammalian chromosome aberration , 40 CFR 799 .9537 (OECD473). 

# ..1ChemStewards APROGRAMOFSQCMA 1850 M St

**~W** Surt(' /00

**·W~sh** ngton 

### :::>e 200lb 'i8 0 • T I 201 721 4100 • F x 202 296 812C • www. ow11Members of the COPS-1 consortium are the following companies : AkzoNobel Surface Chemistry LLC Ashland Inc. Bimax Inc. GE Water & Process Technologies Solvay USA, Inc. 

# SOCMA

These submissions should satisfy the requirements of the above-listed companies to be in compliance with the subject test rule . For further information or questions, please contact the undersigned directly at 202- 721-4154 or helmest@socma.com .

Cc: Dr. John Schaeffer C. Tucker Helmes, Ph .D. Executive Director COPS-1 Consortium

APROGRAM Of

### SOCMA 18SC t"' St NW Su tl. 100 •Wa h1115t DC. 20036 5810 • C'' lC2 121 4100 • fu 202 296 8120 • www.soc
April 19, 2012

JUDGMENT

The Fourteenth Court of Appeals

DAMION J. POTTS, Appellant

NO. 14-10-01172-CR V.

THE STATE OF TEXAS, Appellee

____________________

This cause was heard on the transcript of the record of the court below. Having 

considered the record, this Court holds that there was no error in the judgment. The 

Court orders the judgment AFFIRMED and that this decision be certified below for 

observance.
Michigan Supreme Court

Lansing, Michigan

Bridget M. McCormack, Chief Justice

David F. Viviano,

Chief Justice Pro Tem

Stephen J. Markman

Brian K. Zahra

Richard H. Bernstein

Elizabeth T. Clement

Megan K. Cavanagh,

Justices

Order 

January 24, 2020

158852 & (84)

DETROIT ALLIANCE AGAINST THE RAIN

TAX, DETROIT IRON & METAL COMPANY,

AMERICAN IRON & METAL COMPANY,

McNICHOLS SCRAP IRON & METAL

COMPANY, MONIER KHALIL LIVING TRUST,

and BAGLEY PROPERTIES, LLC,

Plaintiffs-Appellants,

v SC: 158852

COA: 339176

CITY OF DETROIT, DETROIT WATER AND

SEWERAGE DEPARTMENT, and DETROIT 

BOARD OF WATER COMMISSIONERS,

Defendants-Appellees. 

_________________________________________/

On order of the Court, the motion for leave to file supplemental authority is 

GRANTED. The application for leave to appeal the November 6, 2018 judgment of the 

Court of Appeals is considered. We direct the Clerk to schedule oral argument on the 

application. MCR 7.305(H)(1). 

The appellants shall file a supplemental brief within 42 days of the date of this 

order addressing whether the Court of Appeals erred in concluding that Bolt v City of 

Lansing, 459 Mich 152, 164 (1998), is distinguishable from this case on the basis that 

Detroit’s sewer system is a combined system rather than a separate storm and sanitary 

sewer system. 1963 Const, art 9, § 31. In addition to the brief, the appellants shall 

electronically file an appendix conforming to MCR 7.312(D)(2). In the brief, citations to 

the record must provide the appendix page numbers as required by MCR 7.312(B)(1). 

The appellees shall file a supplemental brief within 21 days of being served with the 

appellants’ brief. The appellees shall also electronically file an appendix, or in the 

alternative, stipulate to the use of the appendix filed by the appellants. A reply, if any, 

must be filed by the appellants within 14 days of being served with the appellees’ brief. 

The parties should not submit mere restatements of their application papers. 
I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 January 24, 2020

s0121

2

Clerk

Trappers Properties, et al., is invited to file a brief amicus curiae. Other persons or 

groups interested in the determination of the issues presented in this case may move the 

Court for permission to file briefs amicus curiae.
<TABLE> <S> <C>
                      

<ARTICLE>                   5
<LEGEND>
                            The Schedule contains summary financial information
                            extracted from the financial statements for Freedom
                            Tax Credit Plus L.P. and is qualified in its
                            entirety by reference to such financial statements
</LEGEND>
<CIK>                       0000854926                  
<NAME>                      Freedom Tax Credit Plus L.P.
<MULTIPLIER>                1
                            
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                       MAR-31-1999
<PERIOD-START>                           APR-1-1998
<PERIOD-END>                            SEP-30-1998
<CASH>                                    5,680,730
<SECURITIES>                                157,673
<RECEIVABLES>                                     0
<ALLOWANCES>                                      0
<INVENTORY>                                       0
<CURRENT-ASSETS>                          1,216,698
<PP&E>                                  142,329,639
<DEPRECIATION>                           37,072,919
<TOTAL-ASSETS>                          114,307,884
<CURRENT-LIABILITIES>                    79,969,765
<BONDS>                                           0
<PREFERRED-MANDATORY>                             0
<PREFERRED>                                       0
<COMMON>                                          0
<OTHER-SE>                               34,338,119
<TOTAL-LIABILITY-AND-EQUITY>            114,307,884
<SALES>                                           0
<TOTAL-REVENUES>                          6,941,244
<CGS>                                             0
<TOTAL-COSTS>                                     0
<OTHER-EXPENSES>                          6,929,747
<LOSS-PROVISION>                                  0
<INTEREST-EXPENSE>                        2,440,910
<INCOME-PRETAX>                          (2,429,413)
<INCOME-TAX>                                      0
<INCOME-CONTINUING>                               0
<DISCONTINUED>                                    0
<EXTRAORDINARY>                                   0
<CHANGES>                                         0
<NET-INCOME>                             (2,403,215)
<EPS-PRIMARY>                                (32.64)
<EPS-DILUTED>                                     0
        


</TABLE>